Results 191 to 200 of about 103,076 (260)

Prevalence of Metabolic‐Associated Steatotic Liver Disease in Patients With Primary Aldosteronism

Clinical Endocrinology, Volume 102, Issue 6, Page 618-625, June 2025.
ABSTRACT Objective To assess the prevalence of metabolic associated steatotic liver disease (MASLD) in patients with primary aldosteronism (PA) compared to benign adrenal adenomas, and to evaluate the impact of hormonal excess in inducing MASLD. Design Single‐centre retrospective study. Methods Hepatic steatosis was assessed by liver/spleen (L/S) ratio
Irene Tizianel, Alberto Madinelli, Filippo Crimì, Mattia Barbot, Simona Censi, Chiara Sabbadin, Filippo Ceccato   +6 more
wiley   +1 more source

‘Case of the Month’ from the University of Verona, Italy—navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case

BJU International, Volume 135, Issue 5, Page 743-747, May 2025.
Lorenzo Pierangelo Treccani, Francesco Artoni, Claudio Brancelli, Alessandro Veccia, Mirko D'Onofrio, Isabella Pichiri, Matteo Brunelli, Riccardo Giuseppe Bertolo, Alessandro Antonelli   +8 more
wiley   +1 more source

Morning Salivary Cortisone Versus Serum Cortisol in the Overnight Dexamethasone Suppression Test (ODNST): Evaluation in a Clinical Setting

Clinical Endocrinology, EarlyView.
ABSTRACT Introduction Saliva hormone measurement is increasingly being applied in everyday clinical practice. In relation to salivary cortisone measurement, there is a particular advantage, with minimal chance of cross‐reaction with prescribed glucocorticoids and greater convenience.
Mathilde Mordaunt, Adrian Heald, Waseem Majeed, Rupinder Kochhar, Akheel Syed, Rajshekhar N. Mudaliar, Ramadan Alshames, Fahmy Hanna, David Marshall, Brian Keevil, Anthony A. Fryer   +10 more
wiley   +1 more source

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder, Cherie Chiang, Grace Kong, Michael Michael, Nirupa Sachithanandan, Emma Boehm   +5 more
wiley   +1 more source

Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary Centre

Clinical Endocrinology, EarlyView.
ABSTRACT Background Clinical guidelines recommend genetic counselling for all patients with pheochromocytoma or paraganglioma (PPGL). Barriers to accessing genetics evaluation are incompletely understood. The objective of this study was to identify individual‐ and provider‐level barriers to genetic testing.
Brian Ruhle, Na Eun Kim, Sang Ngo, Elena G. Hughes, Dipti P. Sajed, Run Yu, James X. Wu, Michael W. Yeh, Masha J. Livhits   +8 more
wiley   +1 more source

Determination of Androgen Bioactivity by an In Vitro Assay During Pubertal Transition in Healthy Boys

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To describe the bioactivity of circulating androgens during pubertal transition as determined by an in vitro bioassay assessing androgen receptor (AR) activation, and to compare these findings with circulating concentrations of total testosterone (total T) measured by LC‐MS/MS.
Andrés Felipe Ø. Fritzbøger, Lise Aksglaede, Trine Holm Johannsen, Dirk Vanderschueren, Leen Antonio, Frank Claessens, Katrine Harpelunde Poulsen, Anne Jørgensen, Jørgen Holm Petersen, Anna‐Maria Andersson, Anders Juul   +10 more
wiley   +1 more source

Cytological Assessment of Adrenal Tumours: Insights From 22‐Years Single Centre Experience

Clinical Endocrinology, EarlyView.
ABSTRACT Objective The incidence of adrenal tumours has increased in the last decades, mainly due to increased use of imaging. The diagnostic evaluation of adrenal masses can be complex and, in some cases, necessitates cytological evaluation. However, concerns remain regarding the potential complications associated with adrenal gland biopsy.
Ana Carasel, Jan Calissendorff, C. Christofer Juhlin, Henrik Falhammar   +3 more
wiley   +1 more source

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

Clinical Endocrinology, EarlyView.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Salivary Testosterone, Androstenedione and 11‐Oxygenated 19‐Carbon Concentrations Differ by Age and Sex in Children

Clinical Endocrinology, EarlyView.
ABSTRACT Background The diagnosis and management of childhood adrenal disorders is challenging. Clinical markers of hormone excess or deficiency may take months to manifest, and traditional biomarkers correlate only partially with clinical outcomes.
Julie Park, Andrew Titman, Orla Bright, Silothabo Dliso, Alena Shantsila, Gregory Y. H. Lip, Jo Adaway, Brian Keevil, Daniel B. Hawcutt, Joanne Blair   +9 more
wiley   +1 more source